SAB Biotherapeutics

SABS

Market cap $180M

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$11.33

199% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
UBS Michael Yee 100% 1-yr SABS win rate				7 Jan ‘26 1 month ago
Guggenheim Yatin Suneja 0% 1-yr SABS win rate				19 Dec ‘25 2 months ago
Chardan Capital Keay Nakae 83% 1-yr SABS win rate				18 Dec ‘25 2 months ago